SANGAMO THERAPEUTICS, INC - SGMO

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$98K
QoQ value delta ($000)
-$26.54M (-99.63%)
Implied price effect (QoQ)
-76.3%
Shares
Total shares
1,677,479
QoQ shares delta
-106,366,974 (-98.45%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (SGMO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 7 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
JANE STREET GROUP, LLC 32 609,900 0.0%
SIMPLEX TRADING, LLC 29 555,000 0.0%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 22 400,000 0.0%
VectorGlobal IAG, Inc. 7 30,838 0.0%
Sandbox Financial Partners, LLC 6 24,833 0.0%
FLOW TRADERS U.S. LLC 1 21,532 0.0%
Axiom Investment Management LLC 1 25,375 0.0%
BARCLAYS PLC 0 1 0.0%
Heritage Investment Group, Inc. 0 10,000 0.0%